DNA Chip Research Inc. (2397.T)
JPY 653.0
(-1.51%)
JPY 653.0
(-1.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -140.23 Million | -336.71 Million | -72.97 Million | -76.01 Million | -259 Million |
| Net Income | -246.39 Million | -360.99 Million | -133.09 Million | -171.52 Million | -128 Million |
| Depreciation & Amortization | 41.85 Million | 17.81 Million | 16.47 Million | 21.62 Million | 18 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 4.35 Million | 39.93 Million | 26.14 Million | 63.31 Million | -149 Million |
| Other non-cash items | 60.25 Million | -36.23 Million | 8.06 Million | 10.84 Million | 69.54 Million |
| Investing Cash Flow | -15.77 Million | -155.39 Million | -58.67 Million | -51.39 Million | -95 Million |
| Investments in PPE | -15.86 Million | -126.12 Million | -58.67 Million | -51.39 Million | -27 Million |
| Acquisitions | - | - | - | - | 515 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 85 Thousand | -29.26 Million | -51 Million | -42 Million | -42.69 Million |
| Financing Cash Flow | 269.05 Million | 278.31 Million | - | 445.83 Million | -1 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -23 Thousand | - |
| Common Stock Issuance | 269.05 Million | 278.31 Million | - | 445.86 Million | - |
| Other Financing Activities | 269 Million | 278 Million | - | -1000.00 | -1.44 Million |
| Accounts receivables | -10 Million | -6 Million | -23 Million | 16 Million | -31 Million |
| Accounts payables | 16.46 Million | 6.14 Million | 4.43 Million | -963 Thousand | -3.48 Million |
| Inventory | -49.13 Million | -8.34 Million | -5.04 Million | 6.76 Million | 1 Million |
| Other working capital | 103 Million | 29 Million | 55 Million | 57 Million | -119 Million |
| Cash at beginning of period | 275.36 Million | 489.15 Million | 620.8 Million | 302.37 Million | 658 Million |
| Cash at end of period | 388.4 Million | 275.36 Million | 489.15 Million | 620.8 Million | -355 Million |
| Capital Expenditure | -15.86 Million | -126.12 Million | -58.67 Million | -51.39 Million | -27 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 113.04 Million | -213.79 Million | -131.64 Million | 318.42 Million | -1.01 Billion |
| Free Cash Flow | -156.09 Million | -462.84 Million | -131.64 Million | -127.41 Million | -286 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20 Million | -11 Million | -246.39 Million | -76 Million | -65 Million | -96 Million |
| Depreciation & Amortization | - | - | 41.85 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 4.35 Million | - | - | - |
| Other non-cash items | 20 Million | 11 Million | 60.25 Million | 76 Million | 65 Million | 96 Million |
| Investing Cash Flow | - | - | -15.77 Million | - | - | - |
| Investments in PPE | - | - | -15.86 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 85 Thousand | - | - | - |
| Financing Cash Flow | - | - | 269.05 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 269.05 Million | - | - | - |
| Other Financing Activities | - | - | 269 Million | - | - | - |
| Accounts receivables | - | - | -10 Million | - | - | - |
| Accounts payables | - | - | 16.46 Million | - | - | - |
| Inventory | - | - | -49.13 Million | - | - | - |
| Other working capital | - | - | 103 Million | - | - | - |
| Cash at beginning of period | - | - | 275.36 Million | - | - | - |
| Cash at end of period | - | - | 388.4 Million | - | - | - |
| Capital Expenditure | - | - | -15.86 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 113.04 Million | - | - | - |
| Free Cash Flow | - | - | -156.09 Million | - | - | - |
600051
ORXGF
NOA
600079
PERSISTENT
LIS